SE8902288D0 - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8902288D0
SE8902288D0 SE8902288A SE8902288A SE8902288D0 SE 8902288 D0 SE8902288 D0 SE 8902288D0 SE 8902288 A SE8902288 A SE 8902288A SE 8902288 A SE8902288 A SE 8902288A SE 8902288 D0 SE8902288 D0 SE 8902288D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
ranitidine
bicarbonate
acceptable salt
physiologically acceptable
Prior art date
Application number
SE8902288A
Other languages
English (en)
Other versions
SE502285C2 (sv
SE8902288L (sv
Inventor
A E E Scheffer
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of SE8902288D0 publication Critical patent/SE8902288D0/sv
Publication of SE8902288L publication Critical patent/SE8902288L/sv
Publication of SE502285C2 publication Critical patent/SE502285C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8902288A 1988-06-24 1989-06-22 Brusande farmaceutisk komposition innehållande ranitidin, samt förfarande för dess framställning SE502285C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8808497A FR2633181B1 (fr) 1988-06-24 1988-06-24 Composition pharmaceutique a base de ranitidine et son procede de preparation

Publications (3)

Publication Number Publication Date
SE8902288D0 true SE8902288D0 (sv) 1989-06-22
SE8902288L SE8902288L (sv) 1989-12-25
SE502285C2 SE502285C2 (sv) 1995-09-25

Family

ID=9367671

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902288A SE502285C2 (sv) 1988-06-24 1989-06-22 Brusande farmaceutisk komposition innehållande ranitidin, samt förfarande för dess framställning

Country Status (32)

Country Link
US (1) US5102665A (sv)
JP (1) JPH0786086B2 (sv)
KR (1) KR940002662B1 (sv)
AT (1) AT396426B (sv)
AU (1) AU627194B2 (sv)
BE (1) BE1005691A4 (sv)
CA (1) CA1329130C (sv)
CH (1) CH679276A5 (sv)
CY (1) CY1637A (sv)
CZ (1) CZ280886B6 (sv)
DE (1) DE3920626C2 (sv)
DK (1) DK170223B1 (sv)
ES (1) ES2015717A6 (sv)
FR (1) FR2633181B1 (sv)
GB (1) GB2219940B (sv)
HK (1) HK33192A (sv)
HU (1) HU210067A9 (sv)
IE (1) IE60725B1 (sv)
IL (1) IL90731A (sv)
IT (1) IT1232149B (sv)
LU (1) LU87541A1 (sv)
MY (1) MY106412A (sv)
NL (1) NL8901596A (sv)
NZ (1) NZ229698A (sv)
PH (1) PH26018A (sv)
PT (1) PT90962B (sv)
SA (1) SA90100095B1 (sv)
SE (1) SE502285C2 (sv)
SG (1) SG21892G (sv)
SK (1) SK278823B6 (sv)
ZA (1) ZA894787B (sv)
ZW (1) ZW7889A1 (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1002406A5 (fr) * 1988-09-20 1991-01-29 Glaxo Group Ltd Compositions pharmaceutiques.
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5629013A (en) * 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
FR2700669B1 (fr) * 1993-01-22 1995-04-14 Tassoni Jean Pierre Composition effervescente pour la préparation de boissons gazeuses.
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
JP2000511178A (ja) * 1996-05-17 2000-08-29 メルク エンド カンパニー インコーポレーテッド 発泡性ビスホスホネート製剤
US5728401A (en) * 1997-04-16 1998-03-17 Ranbaxy Laboratories, Ltd. Effervescent ranitidine formulations
HUP9701293A3 (en) * 1997-07-25 1999-08-30 Chinoin Gyogyszer Es Vegyeszet New salts without unsavoury taste and pharmaceutical compositions containing them
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
JP4346311B2 (ja) * 2001-04-27 2009-10-21 京都薬品工業株式会社 発泡性坐剤の保存方法
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1558211A2 (en) * 2002-10-30 2005-08-03 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
EP1708686B1 (en) * 2003-12-31 2011-02-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2005065317A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
AU2004311879B2 (en) * 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
CN101484132A (zh) * 2007-07-09 2009-07-15 柏树制药公司 具有合意口味的雷尼替丁制剂
KR20170003414A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 속붕해형 과립환 모발 세정용 조성물
CN105997922A (zh) * 2016-06-12 2016-10-12 佛山市腾瑞医药科技有限公司 一种盐酸雷尼替丁泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1962791A1 (de) * 1969-12-15 1971-06-24 Boehringer Mannheim Gmbh Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
AU627194B2 (en) 1992-08-20
PH26018A (en) 1992-01-29
NL8901596A (nl) 1990-01-16
IT1232149B (it) 1992-01-25
DK170223B1 (da) 1995-07-03
CA1329130C (en) 1994-05-03
ZW7889A1 (en) 1990-02-21
GB8914428D0 (en) 1989-08-09
MY106412A (en) 1995-05-30
CY1637A (en) 1992-11-06
DE3920626C2 (de) 1994-12-22
SK403891A3 (en) 1998-03-04
BE1005691A4 (fr) 1993-12-21
HU210067A9 (en) 1995-02-28
NZ229698A (en) 1991-05-28
SA90100095B1 (ar) 1999-06-30
FR2633181A1 (fr) 1989-12-29
SG21892G (en) 1992-04-16
SE502285C2 (sv) 1995-09-25
ES2015717A6 (es) 1990-09-01
ZA894787B (en) 1990-03-28
JPH0786086B2 (ja) 1995-09-20
CH679276A5 (sv) 1992-01-31
DK314089D0 (da) 1989-06-23
DE3920626A1 (de) 1989-12-28
HK33192A (en) 1992-05-15
IL90731A (en) 1994-04-12
AU3674489A (en) 1990-01-04
FR2633181B1 (fr) 1992-01-10
IE60725B1 (en) 1994-08-10
CZ403891A3 (en) 1993-08-11
DK314089A (da) 1989-12-25
AT396426B (de) 1993-09-27
PT90962A (pt) 1989-12-29
SK278823B6 (sk) 1998-03-04
CZ280886B6 (cs) 1996-04-17
IL90731A0 (en) 1990-01-18
GB2219940B (en) 1992-01-02
KR910000100A (ko) 1991-01-29
SE8902288L (sv) 1989-12-25
GB2219940A (en) 1989-12-28
IT8948116A0 (it) 1989-06-22
LU87541A1 (fr) 1990-02-28
KR940002662B1 (ko) 1994-03-28
ATA154489A (de) 1993-01-15
JPH0245421A (ja) 1990-02-15
PT90962B (pt) 1994-12-30
US5102665A (en) 1992-04-07
IE892047L (en) 1989-12-24

Similar Documents

Publication Publication Date Title
SE8902288L (sv) Farmaceutisk komposition
ATE212235T1 (de) Poröse feste zubereitung, die eine physiologische aktive proteinverbindung enthält
AR018829A1 (es) Formulaciones farmaceuticas solidas de rapida desintegracion, administrables via oral y procedimiento para prepararlos
ES2103587T3 (es) Composiciones terapeuticas ingeribles, estables y absorbibles de nadh y de nadph.
EP0645136A3 (en) Pharmaceutical preparation of the type: physiologically active substance with sustained release.
IT1217445B (it) Composizione farmaceutiche orosolubili contenti acetilcisteina
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
MY119722A (en) Swallow tablet comprising paracetamol.
ES2163461T3 (es) Procedimiento para la obtencion de comprimidos efervescentes.
DE69108022D1 (de) Arzneimittel.
DE69906651T2 (de) Zusammensetzungen mit langsamer Freigabe enthaltend eine Zinkverbindung und Vitamin C-Derivate
FR2653660B1 (fr) Prothese de hanche perfectionnee, du type cervicale pure.
FR2666508B1 (fr) Compositions pharmaceutiques contenant des derives de furanne.
TR25921A (tr) PESTISID ETKINLIGI HAIZ PESTISID ÖZELLIKTE BISIKLOOKTANLAR,BUNLARI IHTIVA EDEN FORMüLASYONLAR VE HAZIRLANMALARINA MAHSUS USULLER.
GR77250B (sv)
ATE102031T1 (de) Pharmazeutische zubereitung.
IT8821119A0 (it) Protesi chirurgiche canalicolari assorbibili.
DE3686177D1 (de) Gut absorbierende pharmazeutische zusammensetzungen.
TH8905EX (th) ของเล่น(ส่วนหัวรูปหน้าคน)

Legal Events

Date Code Title Description
NUG Patent has lapsed